1. Epidemiology of Sarcopenia: Determinants Throughout the Lifecourse
   S. C. Shaw et al, 2017, Calcified Tissue International CrossRef
2. Fasting-Mimicking-Diet does not reduce skeletal muscle function in healthy young adults: a randomized control trial
   Mauro Nardon et al, 2022, European Journal of Applied Physiology CrossRef
3. Acute Sarcopenia after Elective and Emergency Surgery
   Alvin Shrestha et al, 2022, Aging and disease CrossRef
4. Masticatory muscle index for indicating skeletal muscle mass in patients with head and neck cancer
   Sheng-Wei Chang et al, 2021, PLOS ONE CrossRef
5. The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients
   Debora Basile et al, 2019, Journal of Cachexia, Sarcopenia and Muscle CrossRef
6. Sarcopenia is a risk factor for cardiovascular events experienced by patients with critical limb ischemia
   Yutaka Matsubara et al, 2017, Journal of Vascular Surgery CrossRef
7. Surgical Outcome Assessment of Gastrointestinal Malignancies: Opportunity Prediction by Sarcopenia on CT Measurement
   Ümit Mercan et al, 2020, Indian Journal of Surgery CrossRef
8. Assessment and Impact of Phase Angle and Sarcopenia in Palliative Cancer Patients
   Dana A. Pérez Camargo et al, 2017, Nutrition and Cancer CrossRef
9. Histologic subtypes are not associated with the presence of sarcopenia in lung cancer
   Chang Rae Kim et al, 2018, PLOS ONE CrossRef
10. Combined systemic inflammatory immunity index and prognostic nutritional index scores as a screening marker for sarcopenia in patients with locally advanced gastric cancer
    Ping'an Ding et al, 2022, Frontiers in Nutrition CrossRef
11. Defining Sarcopenia in the Indian Population—a Step Forward
    Deeksha Kapoor et al, 2021, Indian Journal of Surgery CrossRef
12. Creatine Supplementation and Resistance Training in Patients With Breast Cancer (CaRTiC Study)
    Aitor Martinez Aguirre-Betolaza et al, 2024, American Journal of Clinical Oncology CrossRef
13. Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy
    Mehmet Asim Bilen et al, 2020, The Oncologist CrossRef
14. Sarcopenia Identification Using Alternative Vertebral Landmarks in Individuals with Lung Cancer
    Cecily A. Byrne et al, 2024, Muscles CrossRef
15. A Powerful Nomogram Based on the Novel D-Index to Predict Prognosis After Surgical Resection of Hepatocellular Carcinoma
    Xia Du et al, 2021, Cancer Management and Research CrossRef
16. Sarkopenie als unabhängiger Prognosefaktor bei Pankreaskarzinom
    Johanna Mandl et al, 2023, Zeitschrift für Gastroenterologie CrossRef
17. Timed Stair-Climbing as a Surrogate Marker for Sarcopenia Measurements in Predicting Surgical Outcomes
    Samantha Baker et al, 2019, Journal of Gastrointestinal Surgery CrossRef
18. Loss of skeletal muscle mass during palliative chemotherapy is a poor prognostic factor in patients with advanced gastric cancer
    Song Ee Park et al, 2020, Scientific Reports CrossRef
19. Feasibility and safety of exercise during chemotherapy in people with gastrointestinal cancers: a pilot study
    Song Ee Park et al, 2023, Supportive Care in Cancer CrossRef
20. Sarcopenia: looking to muscle mass to better manage pancreatic cancer patients
    Debora Basile et al, 2019, Current Opinion in Supportive & Palliative Care CrossRef
21. Psoas Muscle Index Defined by Computer Tomography Predicts the Presence of Postoperative Complications in Colorectal Cancer Surgery
    Zalán Benedek et al, 2021, Medicina CrossRef
22. Prognostic Impact of Sarcopenia’s Occurrence during Radiotherapy in Oropharyngeal Cancer Patients
    Luca Bergamaschi et al, 2023, Cancers CrossRef
23. The Modulation of Adipokines, Adipomyokines, and Sleep Disorders on Carcinogenesis
    Anna Brzecka et al, 2023, Journal of Clinical Medicine CrossRef
24. Sarkopenie als unabhängiger Prognosefaktor bei Pankreaskarzinom
    Johanna Mandl et al, 2023, TumorDiagnostik & Therapie CrossRef